[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Plasma-derived Factor VIII Market Report 2018

March 2018 | 96 pages | ID: UD09F48E559EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Plasma-derived Factor VIII market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Plasma-derived Factor VIII in these regions, from 2013 to 2025 (forecast).
United States Plasma-derived Factor VIII market competition by top manufacturers/players, with Plasma-derived Factor VIII sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Shire (Baxter)
  • Octapharma
  • CSL
  • Grifols
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • 200IU
  • 250IU
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Plasma-derived Factor VIII Market Report 2018

1 PLASMA-DERIVED FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Plasma-derived Factor VIII
1.2 Classification of Plasma-derived Factor VIII by Product Category
  1.2.1 United States Plasma-derived Factor VIII Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Plasma-derived Factor VIII Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 200IU
  1.2.4 250IU
1.3 United States Plasma-derived Factor VIII Market by Application/End Users
  1.3.1 United States Plasma-derived Factor VIII Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 United States Plasma-derived Factor VIII Market by Region
  1.4.1 United States Plasma-derived Factor VIII Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Plasma-derived Factor VIII Status and Prospect (2013-2025)
  1.4.3 Southwest Plasma-derived Factor VIII Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Plasma-derived Factor VIII Status and Prospect (2013-2025)
  1.4.5 New England Plasma-derived Factor VIII Status and Prospect (2013-2025)
  1.4.6 The South Plasma-derived Factor VIII Status and Prospect (2013-2025)
  1.4.7 The Midwest Plasma-derived Factor VIII Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Plasma-derived Factor VIII (2013-2025)
  1.5.1 United States Plasma-derived Factor VIII Sales and Growth Rate (2013-2025)
  1.5.2 United States Plasma-derived Factor VIII Revenue and Growth Rate (2013-2025)

2 UNITED STATES PLASMA-DERIVED FACTOR VIII MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Plasma-derived Factor VIII Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Plasma-derived Factor VIII Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Plasma-derived Factor VIII Average Price by Players/Suppliers (2013-2018)
2.4 United States Plasma-derived Factor VIII Market Competitive Situation and Trends
  2.4.1 United States Plasma-derived Factor VIII Market Concentration Rate
  2.4.2 United States Plasma-derived Factor VIII Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Plasma-derived Factor VIII Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PLASMA-DERIVED FACTOR VIII SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Plasma-derived Factor VIII Sales and Market Share by Region (2013-2018)
3.2 United States Plasma-derived Factor VIII Revenue and Market Share by Region (2013-2018)
3.3 United States Plasma-derived Factor VIII Price by Region (2013-2018)

4 UNITED STATES PLASMA-DERIVED FACTOR VIII SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Plasma-derived Factor VIII Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Plasma-derived Factor VIII Revenue and Market Share by Type (2013-2018)
4.3 United States Plasma-derived Factor VIII Price by Type (2013-2018)
4.4 United States Plasma-derived Factor VIII Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PLASMA-DERIVED FACTOR VIII SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Plasma-derived Factor VIII Sales and Market Share by Application (2013-2018)
5.2 United States Plasma-derived Factor VIII Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PLASMA-DERIVED FACTOR VIII PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Octapharma
  6.2.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Grifols
  6.4.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Greencross
  6.5.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 BPL
  6.7.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Hualan Bio
  6.8.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 RAAS
  6.9.2 Plasma-derived Factor VIII Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 PLASMA-DERIVED FACTOR VIII MANUFACTURING COST ANALYSIS

7.1 Plasma-derived Factor VIII Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Plasma-derived Factor VIII

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Plasma-derived Factor VIII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Plasma-derived Factor VIII Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PLASMA-DERIVED FACTOR VIII MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Plasma-derived Factor VIII Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Plasma-derived Factor VIII Sales Volume Forecast by Type (2018-2025)
11.3 United States Plasma-derived Factor VIII Sales Volume Forecast by Application (2018-2025)
11.4 United States Plasma-derived Factor VIII Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Plasma-derived Factor VIII
Figure United States Plasma-derived Factor VIII Market Size (K Units) by Type (2013-2025)
Figure United States Plasma-derived Factor VIII Sales Volume Market Share by Type (Product Category) in 2017
Figure 200IU Product Picture
Figure 250IU Product Picture
Figure United States Plasma-derived Factor VIII Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Plasma-derived Factor VIII by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure United States Plasma-derived Factor VIII Market Size (Million USD) by Region (2013-2025)
Figure The West Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2025)
Figure United States Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Plasma-derived Factor VIII Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Plasma-derived Factor VIII Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Plasma-derived Factor VIII Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Plasma-derived Factor VIII Sales Share by Players/Suppliers
Figure 2017 United States Plasma-derived Factor VIII Sales Share by Players/Suppliers
Figure United States Plasma-derived Factor VIII Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Plasma-derived Factor VIII Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Plasma-derived Factor VIII Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Plasma-derived Factor VIII Revenue Share by Players/Suppliers
Figure 2017 United States Plasma-derived Factor VIII Revenue Share by Players/Suppliers
Table United States Market Plasma-derived Factor VIII Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Plasma-derived Factor VIII Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Plasma-derived Factor VIII Market Share of Top 3 Players/Suppliers
Figure United States Plasma-derived Factor VIII Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Plasma-derived Factor VIII Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Plasma-derived Factor VIII Product Category
Table United States Plasma-derived Factor VIII Sales (K Units) by Region (2013-2018)
Table United States Plasma-derived Factor VIII Sales Share by Region (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Share by Region (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Market Share by Region in 2017
Table United States Plasma-derived Factor VIII Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Plasma-derived Factor VIII Revenue Share by Region (2013-2018)
Figure United States Plasma-derived Factor VIII Revenue Market Share by Region (2013-2018)
Figure United States Plasma-derived Factor VIII Revenue Market Share by Region in 2017
Table United States Plasma-derived Factor VIII Price (USD/Unit) by Region (2013-2018)
Table United States Plasma-derived Factor VIII Sales (K Units) by Type (2013-2018)
Table United States Plasma-derived Factor VIII Sales Share by Type (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Share by Type (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Market Share by Type in 2017
Table United States Plasma-derived Factor VIII Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Plasma-derived Factor VIII Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Plasma-derived Factor VIII by Type (2013-2018)
Figure Revenue Market Share of Plasma-derived Factor VIII by Type in 2017
Table United States Plasma-derived Factor VIII Price (USD/Unit) by Types (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Growth Rate by Type (2013-2018)
Table United States Plasma-derived Factor VIII Sales (K Units) by Application (2013-2018)
Table United States Plasma-derived Factor VIII Sales Market Share by Application (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Market Share by Application (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Market Share by Application in 2017
Table United States Plasma-derived Factor VIII Sales Growth Rate by Application (2013-2018)
Figure United States Plasma-derived Factor VIII Sales Growth Rate by Application (2013-2018)
Table Shire (Baxter) Basic Information List
Table Shire (Baxter) Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Octapharma Basic Information List
Table Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table CSL Basic Information List
Table CSL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure CSL Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure CSL Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Grifols Basic Information List
Table Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Grifols Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Grifols Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Greencross Basic Information List
Table Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Greencross Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Greencross Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Greencross Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Kedrion Basic Information List
Table Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table BPL Basic Information List
Table BPL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BPL Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure BPL Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure BPL Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Hualan Bio Basic Information List
Table Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table RAAS Basic Information List
Table RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure RAAS Plasma-derived Factor VIII Sales Growth Rate (2013-2018)
Figure RAAS Plasma-derived Factor VIII Sales Market Share in United States (2013-2018)
Figure RAAS Plasma-derived Factor VIII Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma-derived Factor VIII
Figure Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure Plasma-derived Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Plasma-derived Factor VIII Major Players/Suppliers in 2017
Table Major Buyers of Plasma-derived Factor VIII
Table Distributors/Traders List
Figure United States Plasma-derived Factor VIII Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Plasma-derived Factor VIII Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Type in 2025
Table United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Application in 2025
Table United States Plasma-derived Factor VIII Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Plasma-derived Factor VIII Sales Volume Share Forecast by Region (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume Share Forecast by Region (2018-2025)
Figure United States Plasma-derived Factor VIII Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories